Pharma Firm Adds Ulcerative Colitis Drug to Duty-Free Zone List
Published Date: 3/13/2026
Notice
Summary
Patheon API, Inc. in Cincinnati wants to add a new ulcerative colitis drug to their Foreign-Trade Zone production list, which means they can save on import duties for certain materials. This change affects pharmaceutical manufacturing and invites public comments until April 22, 2026. It’s a smart move to keep costs down and boost local drug production!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
FTZ Adds Ulcerative Colitis API
Patheon API, Inc. in Subzone 46K (Cincinnati, Ohio) asked to add an ulcerative colitis active pharmaceutical ingredient (API Ono-6414HY) to its Foreign-Trade Zone production list. The proposed finished product is listed as duty-free when produced under FTZ procedures.
Imported Component Faces 6.5% Duty
The notification identifies a specific foreign-status material/component used in production that carries a duty rate of 6.5%. The request also says this material may be subject to duties under section 301 of the Trade Act of 1974 depending on country of origin, and applicable section 301 decisions require admission to FTZs in privileged foreign status under 19 CFR 146.41.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in